-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On March 17, the official website of the State Administration of Food and Drug Administration showed that Jiangsu Aosaikang Pharmaceutical's dexrazoxane for injection was approved for listing in imitation 3 categories, and it was deemed to have been reviewed.
Data show that dexrazoxane is an anthracycline cardiotoxicity protective agent.
According to data from Menet.
Source: MED2.
At present, the supplementary application for consistency evaluation of dexrazoxane for injection previously approved by Jiangsu Aosaikang Pharmaceutical is under review and approval; Shanghai Kaimao Biomedicine | Shanghai Longsha Fosun Pharmaceutical, Nanjing Zhengda Tianqing Pharmaceutical are all using generic 3 Submission of a listing application for this category is under review and approval, and after approval, it is deemed to have been reviewed.
Source: official website of the State Food and Drug Administration, Mi Nei.